In SURMOUNT-1, at the 15 mg dose over 72 weeks, 91% of participants lost at least 5% of their body weight, 83.5% lost at least 10%, 70.6% lost at least 15%, and 56.7% lost at least 20%
Brand Name Medication Notice The following GLP-1 medications are only available through their respective manufacturers: Wegovy and Ozempic exclusively available from Novo Nordisk Mounjaro and Zepbound exclusively available from Eli Lilly and Company Affinity Whole Health is not affiliated with or endorsed by these brands, and we do not offer these medications
Use trained personnel, appropriate engineering controls, personal protective equipment, contamination controls, and lawful disposal methods
High-dose B12, particularly intramuscular injections delivering 1,000 micrograms or more, appears more likely to trigger acne than standard dietary intake or lower-dose oral supplements